
Keywords: کسر ناخواسته در پلاسما; Ceritinib; Reversed-phase liquid chromatography with tandem mass spectrometry (LC-MS/MS); Fraction unbound in plasma; Fraction unbound in brain tissue; Brain tumor penetration; Unbound brain-to-plasma partition coefficient;